User talk:Nicowalker

Welcome!

Hello, Nicowalker, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are some pages that you might find helpful:

I hope you enjoy editing here and being a Wikipedian! Please sign your name on talk pages using four tildes (~~~~); this will automatically produce your name and the date. If you need help, check out Wikipedia:Questions, ask me on my talk page, or ask your question and then place {{helpme}} after the question on your talk page. Again, welcome! Fvasconcellos 22:18, 11 March 2007 (UTC)[reply]

WikiProject Pharmacology Collaboration of the Week

WikiProject Pharmacology is currently organizing a new Collaboration of the Week program, designed to bring drug and medication related articles up to featured status. We're currently soliciting nominations and/or voting on nominations for the first WP:RxCOTW, to begin on September 5, 2007. Please stop by the Pharmacology Collaboration of the Week page to participate! Thanks! Dr. Cash 17:52, 1 September 2007 (UTC)[reply]

Pharmacology Collaboration of the Week

Aspirin has been selected as this week's Pharmacology Collaboration of the Week! Please help us bring this article up to featured standards during the week. The goal is to nominate this at WP:FAC on September 10, 2007.

Also, please visitWP:RxCOTW to support other articles for the next COTW. Articles that have been nominated thus far include Doxorubicin, Paracetamol (in the lead with 4 support votes so far), Muscle relaxant, Ethanol, and Bufotenin.

In other news:

Bupropion has been promoted to featured status on August 31, 2007.

The Wikipedia:WikiProject Pharmacology main page has been updated and overhauled, to make it easier to find things, as well as to highlight other goals and announcements for the project.

Garrondo is asking for individuals to help review Therapies for multiple sclerosis, as he is considering nominating this article for GA status.

Fvasconcellos notes that discussion is ongoing regarding the current wording of MEDMOS on including dosage information in drug articles. All input is welcome.

Dr. Cash 00:50, 5 September 2007 (UTC)[reply]

WikiProject Pharmacology Update

Here's a brief update in some of the recent developments of WikiProject Pharmacology!

Aspirin has just completed its two week run as the first Collaboration of the Week! Many thanks to those editors that contributed; the article got a lot of good work accomplished, and in particular, much work was done in fixing up the history section. It's still not quite "done" yet (is a wikipedia article really ever done?), but after two weeks I think it's more important to push onwards with the development of the new collaboration of the week program. I will be fixing up Aspirin in the next few days and possibly nominating it for either GA or FA status.

Muscle relaxant has been selected as the new Collaboration of the week until October 2, 2007! This article is currently rated as a "stub", so it's got quite a bit of work cut out for collaborators! Admittedly, featured status could be a long way off,... but still attainable! At the least, maybe we could at least get it up to meeting the Good article criteria? Please stop by the article and help improve it.

Resveratrol, having recently achieved GA status on August 16, 2007, is now making a run for featured status. This is quite a fascinating compound. If you can, please stop by its discussion page and leave comments in support of it.

Please remember that Wikipedia is not a forum for discussing or dispensing medical advice amongst users. Specifically, talk pages of articles should only be used to discuss improving the actual article in question. To help alleviate this situation, the template {{talkheader}} may be added to the top of talk pages, reminding users of the purpose of such pages. Additionally, unsigned comments and comments by anonymous users that are inappropriate may be removed from talk pages without being considered vandalism.

There was an interesting article on ZDNet last week about Hewlett Packard licensing its patented microneedle technology used in common inkjet printers to be used in transdermal patches to deliver a time-controlled release of drugs to patients. This information could be added to articles such as route of administration or drug delivery.

You are receiving this message because you are listed as one of the participants of WikiProject Pharmacology.

Dr. Cash 04:56, 19 September 2007 (UTC)[reply]

WikiProject Pharmacology Update

Here are a few updates in the realm of WikiProject Pharmacology:

The Pharmacology Collaboration of the Week has been changed to Collaboration of the Month, based on current participation levels. It is also more likely that articles collaborated on for one month are more likely to achieve featured quality than articles worked on for only a week or two.

The current Collaboration of the Month for November is Receptor antagonist. Please take a look at that article and contribute to it if you get a chance. Ideally, the article should adhere to the featured article criteria.

Therapies for multiple sclerosis is currently a featured article candidate. If you are familiar with the featured article criteria, please visit WP:FAC and review the article.

Anabolic steroid is the wikiproject's newest Featured Article, having been promoted on October 8, 2007.

Theobromine was delisted as a Good Article. The Peer review and GA reassessment discussions provide suggestions on improvement. Muscle relaxant was recently reviewed for Good Article status, but not promoted. Please see the full review full review here for details.

Dr. Cash 22:15, 31 October 2007 (UTC)[reply]

Electron Club

This is an automated message from VWBot. I have performed a web search with the contents of Electron Club, and it appears to be a substantial copy of http://www.electronclub.org.

It is possible that the bot is confused and found similarity where none actually exists. If that is the case, you can remove the tag from the article. The article will be reviewed to determine if there are any copyright issues.

If substantial content is duplicated and it is not public domain or available under a compatible license, it will be deleted. For legal reasons, we cannot accept copyrighted text or images borrowed from other web sites or printed material. You may use such publications as a source of information, but not as a source of sentences. See our copyright policy for further details. (If you own the copyright to the previously published content and wish to donate it, see Wikipedia:Donating copyrighted materials for the procedure.) VWBot (talk) 14:11, 7 May 2011 (UTC)[reply]

Speedy deletion nomination of Electron Club

If this is the first article that you have created, you may want to read the guide to writing your first article.
You may want to consider using the Article Wizard to help you create articles.

A tag has been placed on Electron Club requesting that it be speedily deleted from Wikipedia. This has been done under section A7 of the criteria for speedy deletion, because the article appears to be about web content, but it does not indicate how or why the subject is important or significant: that is, why an article about that subject should be included in an encyclopedia. Under the criteria for speedy deletion, such articles may be deleted at any time. Please see the guidelines for what is generally accepted as notable.

If you think that this notice was placed here in error, contest the deletion by clicking on the button labelled "Click here to contest this speedy deletion," which appears inside of the speedy deletion ({{db-...}}) tag (if no such tag exists, the page is no longer a speedy delete candidate). Doing so will take you to the talk page where you will find a pre-formatted place for you to explain why you believe the page should not be deleted. You can also visit the the page's talk page directly to give your reasons, but be aware that once tagged for speedy deletion, if the page meets the criterion, it may be deleted without delay. Please do not remove the speedy deletion tag yourself, but don't hesitate to add information to the page that would render it more in conformance with Wikipedia's policies and guidelines. If the page is deleted, you can contact one of these administrators to request that the administrator userfy the page or email a copy to you. Cntras (talk) 14:26, 7 May 2011 (UTC)[reply]

Removing Speedy at Electron Club

Welcome to Wikipedia. It might not have been your intention, but you removed a speedy deletion tag from Electron Club, a page you have created yourself. If you do not believe the page should be deleted, then you may contest the deletion by clicking on the button that looks like this: which appears inside of the speedy deletion notice, which will allow you to make your case on the page's talk page. Administrators will look at your reasoning before deciding what to do with the page. Thank you. - SDPatrolBot (talk) 14:33, 7 May 2011 (UTC)[reply]

Wikipedian in Residence at the National Library of Scotland

I'm just dropping you a quick note about a new Wikipedian in Residence job that's opened up at the National Library of Scotland. There're more details at Wikipedia talk:WikiProject Scotland#Wikimedian in Residence at the National Library of Scotland. Richard Symonds (WMUK) (talk) 15:17, 22 April 2013 (UTC)[reply]

The Wikipedia Library now offering accounts from Cochrane Collaboration (sign up!)

The Wikipedia Library (talk | edit)

Get free access to research!

...Support Open Access...

Cochrane Collaboration is an independent medical nonprofit organization consisting of over 28,000 volunteers in more than 100 countries. The collaboration was formed to organize medical scholarship in a systematic way in the interests of evidence-based research: the group conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.

Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account. Thank you Cochrane!

If you are stil active as a medical editor, come and sign up :)

Cheers, Ocaasi^{t | c} 20:02, 16 June 2013 (UTC)[reply]